1. Home
  2. FNWD vs LUCD Comparison

FNWD vs LUCD Comparison

Compare FNWD & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$38.78

Market Cap

143.6M

Sector

Finance

ML Signal

N/A

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$1.15

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
LUCD
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.6M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FNWD
LUCD
Price
$38.78
$1.15
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$34.00
$3.94
AVG Volume (30 Days)
41.8K
709.8K
Earning Date
01-27-2026
11-12-2025
Dividend Yield
1.23%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$66,563,999.00
$4,399,000.00
Revenue This Year
N/A
$12.31
Revenue Next Year
$8.03
$152.14
P/E Ratio
$20.44
N/A
Revenue Growth
N/A
5.01
52 Week Low
$26.12
$0.75
52 Week High
$39.99
$1.80

Technical Indicators

Market Signals
Indicator
FNWD
LUCD
Relative Strength Index (RSI) 67.32 61.67
Support Level $36.37 $1.02
Resistance Level $39.99 $1.16
Average True Range (ATR) 1.32 0.05
MACD -0.04 0.02
Stochastic Oscillator 79.16 100.00

Price Performance

Historical Comparison
FNWD
LUCD

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: